Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Delphine Rea

22PUBLICATIONS

77CO-AUTHORS

Haematological tumoursGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (22)

Sort by Publication Date:

|Jan 19, 2026

Treatment-free remission after two nilotinib consolidation durations in chronic myeloid leukemia treated with imatinib: Phase 3 ENESTPath results.

Delphine Rea, Slawomira Kyrcz-Krzemien, Paolo Sportoletti

|Oct 23, 2025

A newcomer in allosteric therapy for Ph+ leukemias.

Delphine Rea

|May 07, 2025

Asciminib remained superior vs bosutinib in late-line CML-CP after nearly 4 years of follow-up in ASCEMBL.

Michael J Mauro, Yosuke Minami, Andreas Hochhaus

|Dec 10, 2024

Mutation of Epigenetic Regulators at Diagnosis Is an Independent Predictor of Tyrosine Kinase Inhibitor Treatment Failure in Chronic Myeloid Leukemia: A Report From the RESIDIAG Study.

Hippolyte Guerineau, Jean-Michel Cayuela, Stéphanie Dulucq

|Sep 02, 2024

Correction: Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials.

Elias Jabbour, Jane Apperley, Jorge Cortes

|Jul 31, 2024

Absence of ABL1 exon 2-encoded SH3 residues in BCR::ABL1 destabilizes the autoinhibited kinase conformation and confers resistance to asciminib.

Ariel Leyte-Vidal, RosaAnna DeFilippis, Ian R Outhwaite

Pageof 4

Frequent Collaborators

5 joint publications

Michael Mauro

5 joint publications

Andreas Hochhaus

5 joint publications

Gabriel Etienne

4 joint publications

Stéphanie Dulucq

4 joint publications

Jane F Apperley

3 joint publications

Jorge Cortes

3 joint publications

Neil P Shah

3 joint publications

Franck E Nicolini

3 joint publications

Susanne Saussele

3 joint publications

Philippe Rousselot

Frequent Collaborators

5 joint publications

Michael Mauro

5 joint publications

Andreas Hochhaus

5 joint publications

Gabriel Etienne

4 joint publications

Stéphanie Dulucq

Top Related Videos

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on : Oct 17, 2025

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on : Mar 14, 2011

<i>Ex Vivo</i> Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

<i>Ex Vivo</i> Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on : Mar 29, 2024

See more related videos

Top Related Videos

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on : Oct 17, 2025

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on : Mar 14, 2011

<i>Ex Vivo</i> Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

<i>Ex Vivo</i> Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on : Mar 29, 2024

See more related videos